2025年欧洲肿瘤内科学会亚洲年会（ESMO Asia Congress 2025）将于12月5日—12月7日在新加坡举行。目前，官网已公布摘要题目及作者信息。【肿瘤资讯】特此整理在研疗法和精准医学领域的口头报告摘要标题，以飨读者。
摘要号：LBA2
英文标题：Rezatapopt for Advanced Solid Tumours with a TP53 Y220C mutation: Initial analysis of the PYNNACLE Phase 2 study
中文标题：Rezatapopt治疗伴有TP53 Y220C突变的晚期实体瘤：PYNNACLE II期研究的初步分析
讲者：David SP Tan (Singapore, SG)
摘要号：LBA7
英文标题：ProSight: the first prospective interventional trial of multi-cancer early detection (MCED) test among asymptomatic population in China
中文标题：ProSight：中国首个针对无症状人群的多癌种早期检测（MCED）前瞻性干预试验
讲者：Miaoyan Wei (上海)
摘要号：158O
英文标题：A phase 1 first-in-human study of BPB-101, a novel triple functional bispecific antibody targeting GARP/TGF-β complex and PD-L1, in patients with locally advanced or metastatic solid tumors
中文标题：一项BPB-101（一种靶向GARP/TGF-β复合物和 PD-L1的新型三功能双特异性抗体）在局部晚期或转移性实体瘤患者中的1期首次人体研究
讲者：Yuxiang Ma (广州)
摘要号：159O
英文标题：First-in-human study of ES014, a bispecific antibody targeting CD39 and TGF-β as monotherapy in patients with advanced solid tumors
中文标题：ES014（一种靶向CD39和TGF-β的双特异性抗体）单药治疗晚期实体瘤患者的首次人体研究
讲者：Zhen Zhou (上海)
摘要号：160MO
英文标题：BL-M07D1, a novel anti-HER2 antibody-drug conjugate (ADC), in subjects with metastatic HER2-mutant non-small cell lung cancer (NSCLC)
中文标题：新型抗HER2抗体药物偶联物（ADC）BL-M07D1治疗HER2突变型转移性非小细胞肺癌（NSCLC）患者的研究
讲者：Jinhui Xue (广州)
摘要号：161MO
英文标题：Safety and tolerability of a novel PARP7 inhibitor QLS1103 in patients with advanced solid tumors: results from a phase 1 trial
中文标题：新型PARP7抑制剂QLS1103在晚期实体瘤患者中的安全性与耐受性：一项I期试验的结果
讲者：陈华军 广东省人民医院
摘要号：162MO
英文标题：A first-in-human (FIH), dose escalation study of HMPL-A83 (A83), an anti-CD47 monoclonal antibody (mAb) in patients (pts) with advanced solid tumors
中文标题：HMPL-A83（A83，一种抗CD47单克隆抗体）治疗晚期实体瘤患者的首次人体（FIH）剂量爬坡研究
讲者：郭晔 上海市东方医院
摘要号：163MO
英文标题：First-in-human phase 1 study of the anti-TIGIT and PVRIG bispecific antibody as monotherapy or with sintilimab for advanced solid tumors
中文标题：抗TIGIT和PVRIG双特异性抗体单药治疗或联合信迪利单抗治疗晚期实体瘤的首次人体I期研究
讲者：Jinhui Xue (广州)
摘要号：762MO
英文标题：Clinical whole genome and transcriptome sequencing for cancer of unknown primary: An Australian prospective observational study
中文标题：用于原发灶不明（CUP）癌症的临床全基因组和转录组测序：一项澳大利亚前瞻性观察研究
讲者：Richard J. Rebello (Parkville, AU)
摘要号：763MO
英文标题：Multimodal Profiling of Cancer of Unknown Primary with and without Subsequent Diagnosis: Does Assigning a Primary Tumor Matter?
中文标题：对后续诊断明确和未明确的原发灶不明（CUP）癌症进行多模态分析：确定原发灶是否重要？
讲者：Sajjad Rostami (Amsterdam, NL)
摘要号：764MO
英文标题： Efficacy of tyrosine kinase inhibitors (TKI) by mRNA Expression of Targeted Genes in Advanced Solid Tumors: SCRUM-Japan MONSTAR-SCREEN-2
中文标题：根据靶基因mRNA表达水平评估酪氨酸激酶抑制剂（TKI）在晚期实体瘤中的疗效：SCRUM-Japan MONSTAR-SCREEN-2研究
讲者：Takao Fujisawa (Kashiwa, JP)
摘要号：765MO
英文标题： Comprehensive genomic and transcriptomic characterization of MTAP loss across advanced solid tumors: SCRUM-Japan MONSTAR-SCREEN-1 and 2
中文标题：晚期实体瘤中MTAP缺失的全面基因组学和转录组学特征分析：SCRUM-Japan MONSTAR-SCREEN-1和2研究
讲者：Kyosuke Seguchi (Kashiwa, JP)
如有遗漏，欢迎留言补充！
排版编辑：肿瘤资讯-Bear
苏公网安备32059002004080号
